JP Morgan Chase’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$388K Sell
7,563
-50
-0.7% -$2.79K ﹤0.01% 5168
2025
Q4
$426K Sell
7,613
-51,086
-87% -$2.65M ﹤0.01% 5133
2025
Q3
$2.81M Buy
58,699
+1,441
+3% +$64.4K ﹤0.01% 3817
2025
Q2
$2.32M Buy
57,258
+4,918
+9% +$198K ﹤0.01% 3800
2025
Q1
$2.29M Sell
52,340
-300
-0.6% -$13.2K ﹤0.01% 3778
2024
Q4
$2.26M Buy
52,640
+48,197
+1,085% +$2.19M ﹤0.01% 4053
2024
Q3
$197K Buy
4,443
+1,182
+36% +$50.6K ﹤0.01% 5410
2024
Q2
$130K Buy
3,261
+2,271
+229% +$92K ﹤0.01% 5383
2024
Q1
$42.7K Sell
990
-8,133
-89% -$350K ﹤0.01% 6001
2023
Q4
$380K Buy
9,123
+8,784
+2,591% +$333K ﹤0.01% 4966
2023
Q3
$13.5K Hold
339
﹤0.01% 6177
2023
Q2
$13.9K Sell
339
-60
-15% -$2.48K ﹤0.01% 5994
2023
Q1
$16K Buy
399
+60
+18% +$2.52K ﹤0.01% 6026
2022
Q4
$14K Hold
339
﹤0.01% 5978
2022
Q3
$14K Sell
339
-103,959
-100% -$4.45M ﹤0.01% 5901
2022
Q2
$4.38M Buy
104,298
+43,959
+73% +$1.84M ﹤0.01% 2891
2022
Q1
$2.73M Buy
60,339
+32,581
+117% +$1.43M ﹤0.01% 3507
2021
Q4
$1.28M Buy
27,758
+23,419
+540% +$1.11M ﹤0.01% 4210
2021
Q3
$206K Sell
4,339
-29,604
-87% -$1.47M ﹤0.01% 5219
2021
Q2
$1.76M Sell
33,943
-51,341
-60% -$2.58M ﹤0.01% 3887
2021
Q1
$4.29M Sell
85,284
-213,173
-71% -$11.4M ﹤0.01% 3096
2020
Q4
$15.5M Sell
298,457
-28,942
-9% -$1.38M ﹤0.01% 1834
2020
Q3
$14.1M Sell
327,399
-82,367
-20% -$3.61M ﹤0.01% 1759
2020
Q2
$17.6M Sell
409,766
-177,133
-30% -$7.32M ﹤0.01% 1454
2020
Q1
$21.2M Buy
586,899
+586,765
+437,884% +$25M 0.01% 1222
2019
Q4
$6K Sell
134
-1,126,369
-100% -$44.6M ﹤0.01% 5457
2019
Q3
$40.1M Buy
1,126,503
+776,283
+222% +$28.9M 0.01% 1066
2019
Q2
$13.8M Buy
350,220
+250,000
+249% +$9.83M ﹤0.01% 1847
2019
Q1
$4.17M Sell
100,220
-137,985
-58% -$5.61M ﹤0.01% 2732
2018
Q4
$8.72M Buy
238,205
+119,122
+100% +$5.08M ﹤0.01% 2136
2018
Q3
$5.78M Buy
119,083
+114,330
+2,405% +$5.42M ﹤0.01% 2621
2018
Q2
$205K Sell
4,753
-2,732
-36% -$115K ﹤0.01% 4555
2018
Q1
$313K Sell
7,485
-10,904
-59% -$475K ﹤0.01% 4204
2017
Q4
$800K Sell
18,389
-83,330
-82% -$3.54M ﹤0.01% 3846
2017
Q3
$4.29M Buy
101,719
+92,868
+1,049% +$3.94M ﹤0.01% 2668
2017
Q2
$381K Sell
8,851
-20,736
-70% -$874K ﹤0.01% 3821
2017
Q1
$1.24M Buy
29,587
+10,027
+51% +$409K ﹤0.01% 3300
2016
Q4
$765K Buy
19,560
+1,263
+7% +$51.4K ﹤0.01% 3562
2016
Q3
$809K Buy
18,297
+419
+2% +$19K ﹤0.01% 3228
2016
Q2
$747K Buy
17,878
+4,763
+36% +$202K ﹤0.01% 3285
2016
Q1
$528K Buy
13,115
+55
+0.4% +$2.33K ﹤0.01% 3324
2015
Q4
$669K Buy
+13,060
New +$666K ﹤0.01% 3286
2015
Q3
Sell
-10,004
Closed -$623K 4124
2015
Q2
$623K Buy
+10,004
New +$623K ﹤0.01% 3486
2015
Q1
Sell
-8,594
Closed -$464K 4312
2014
Q4
$464K Buy
+8,594
New +$470K ﹤0.01% 3700

Other funds holding XPH